New ingredient listing rules may impact innovative raw-material suppliers
Proprietary Ingredients have long protected trade-secret manufacturing processes by disclosing them only to the TGA. Changes to how ingredients are listed put that commercial tool under pressure.
Written in 2021. The rules may have changed since: for the rules as they stand, see our guides.
Proprietary Ingredients have long been an important item in the Australian industry's commercial toolbox. They protect a raw material by disclosing the trade-secret manufacturing process only to the TGA, under strict confidentiality, so a supplier can bring a novel ingredient to market without handing its competitors the recipe.
Changes to how ingredients are listed put that tool under pressure, and the suppliers most exposed are the innovative ones: the companies investing in new extraction methods, fermentation and standardisation rather than trading commodity botanicals.
For sponsors the practical questions are the same as always. What exactly is in the product, how is it specified, what evidence sits behind it, and does the listing still match the label? Those are the questions the Take Friday Off system answers before a formulation is locked, not after a listing is challenged.
This post is an edited recap of the original article. The full text can be restored through the site CMS.
Related guides
Related guides
TGA approval for supplements: how an AUST L listing works
TGA approval for a supplement usually means an AUST L listing on the ARTG. What AUST L means, the steps, the TGO 116 labels and the 2026–27 fees.
How long does it take to develop a supplement?
How long it takes to develop a supplement, from our records: 32 days from design to production order at the fastest, the stages, and what holds a launch up.
Assessed listed medicines: AUST L(A) claims, fees and timeframes
What an assessed listed medicine (AUST L(A)) can claim, how the TGA evaluates its efficacy, and the 2026–27 fees, timeframes and five-year data protection.
